Dr. Vivek Eranki retired from Medical Practice in 2021 and does not practice medicine, provide clinical care, or any medical guidance in any capacity. He now exclusively serves in Directorial and Executive roles. The title “Dr” is an acknowledgment of his numerous medical qualifications both in Australia and Overseas. The information provided on this website, including in any public forum, including but not limited to commentary made to the public, investors, or news outlets, is general in nature and not intended to be medical advice, treatment, diagnoses, or otherwise promote the use of particular products, remedies or treatments. You are solely responsible for determining the suitability of any advice, products, remedies, treatments, or services for your circumstances and your reliance on the Information is at your own risk. We recommend you consult a Registered Health Practitioner within your jurisdiction before acting on the Information or using the products, remedies, or treatments mentioned.

The views, thoughts, and opinions expressed in this statement are those of Dr Vivek Eranki speaking in his Directorial and/or Executive capacity and do not necessarily reflect the official policy or position of the Company. This statement is intended for informational purposes only and should not be considered legally binding on the Company or as a reflection of the Company’s current or future plans, which are subject to change at any time without notice.

The remarks made herein are purely personal opinions of Dr. Vivek Eranki and do not necessarily represent the views, strategies, or opinions of the Company or its management team. These statements are not endorsed by, nor do they reflect the official stance of, the Company or any of its affiliates.

Any Information, advice, material, or views expressed do not constitute financial, due diligence, or risk management advice. The Information does not consider your personal circumstances. Information on this website may contain forward-looking statements that reflect current beliefs, expectations, or intentions regarding future events, forecasts or performance. These statements are based on information currently available to us and are subject to risks, uncertainties, assumptions, and other factors that could cause actual results to differ materially from those projected. We undertake no obligation to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Reliance on these forward-looking statements is at your own risk. If you require advice, speak to a licensed or registered financial professional. We do not accept any liability for any injury, loss, or damage incurred using or reliance on the Information.

Dr. Vivek Eranki has garnered a distinguished reputation as the Chief Executive Officer (CEO) of Cosmetique®.

With a proclivity for entrepreneurship, he has also founded, scaled, and managed business operations in diverse fields, ranging from Allied and Occupational Health to General and Specialist Healthcare.

Possessing a formidable educational foundation, Dr. Eranki has garnered an array of medical and corporate credentials that span both Australian and international landscapes.

His medical knowledge is substantiated by a Master of Medicine and Surgery degree from the University of Notre Dame, further enriched by Fellowships and Associate Fellowships in areas such as General Practice, Medical Administration, and Cosmetic Surgery. Dr. Vivek Eranki retired from Medical Practice in 2021 and does not practice medicine, provide clinical care, or any medical guidance in any capacity. He now exclusively serves in Directorial and Executive roles.

Dr. Eranki holds formal training in Corporate Finance and is a Graduate of the Australian Institute of Company Directors, a Fellow of the Australian Institute of Management, and an Associate of the Governance Institute of Australia.

Dr. Eranki excels in his role by drawing upon his extensive experience, comprehensive training, and diverse background in healthcare, business, and corporate governance.